av/entera-bio--big.svg

NASDAQ:ENTX

Entera Bio Ltd.

  • Stock

USD

Last Close

3.11

06/11 21:00

Market Cap

64.47M

Beta: 1.84

Volume Today

13.71K

Avg: 246.50K

PE Ratio

−3.78

PFCF: −3.20

OverviewFinancialsAPI

    Description

    Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.4-0.3-0.2-0.10.10.22019-03-282020-11-192022-05-122023-08-112024-09-12

    Revenue (Estimate*)

    100K200K300K400K500K2019-03-282020-11-192022-05-122023-08-112024-09-12

    *Estimate based on analyst consensus